Bo Zhai

8.6k total citations · 1 hit paper
152 papers, 5.4k citations indexed

About

Bo Zhai is a scholar working on Molecular Biology, Surgery and Hepatology. According to data from OpenAlex, Bo Zhai has authored 152 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 45 papers in Surgery and 44 papers in Hepatology. Recurrent topics in Bo Zhai's work include Hepatocellular Carcinoma Treatment and Prognosis (36 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers) and Liver Disease Diagnosis and Treatment (14 papers). Bo Zhai is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (36 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (18 papers) and Liver Disease Diagnosis and Treatment (14 papers). Bo Zhai collaborates with scholars based in China, United States and New Zealand. Bo Zhai's co-authors include Xueying Sun, Hongchi Jiang, Xian Jiang, Steven P. Gygi, Jiachang Chi, Xuesong Dong, Haiquan Qiao, Gang Tan, Yao Shi and Changjun He and has published in prestigious journals such as Nature, Cell and Journal of Biological Chemistry.

In The Last Decade

Bo Zhai

144 papers receiving 5.3k citations

Hit Papers

SCFFBW7 regulates cellular apoptosis by targeting MCL1 fo... 2011 2026 2016 2021 2011 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. SCFFBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction
    2011 537 citations Hiroyuki Inuzuka, Daming Gao et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo Zhai China 37 3.1k 1.4k 1.3k 889 701 152 5.4k
Rishu Takimoto Japan 40 2.6k 0.8× 564 0.4× 1.6k 1.2× 755 0.8× 760 1.1× 155 5.8k
Eiso Hiyama Japan 41 4.0k 1.3× 1.3k 0.9× 1.8k 1.3× 757 0.9× 628 0.9× 230 8.8k
Xueli Bai China 37 1.8k 0.6× 1.2k 0.8× 1.5k 1.1× 540 0.6× 455 0.6× 154 4.2k
Ning Ren China 36 1.8k 0.6× 1.5k 1.1× 985 0.7× 707 0.8× 464 0.7× 113 3.7k
Runqiu Jiang China 33 2.3k 0.7× 1.7k 1.3× 1.0k 0.8× 500 0.6× 818 1.2× 61 4.3k
Qiongzhu Dong China 49 4.5k 1.5× 3.6k 2.6× 1.8k 1.4× 701 0.8× 647 0.9× 131 7.4k
Zhiyong Guo China 39 2.3k 0.7× 1.1k 0.8× 818 0.6× 701 0.8× 665 0.9× 126 5.6k
Jesús M. Bañales Spain 41 2.4k 0.8× 1.3k 0.9× 1.3k 1.0× 1.5k 1.7× 1.3k 1.9× 169 6.0k
Jun Akiba Japan 40 1.3k 0.4× 929 0.7× 1.7k 1.3× 781 0.9× 754 1.1× 309 5.5k

Countries citing papers authored by Bo Zhai

Since Specialization
Citations

This map shows the geographic impact of Bo Zhai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Zhai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Zhai more than expected).

Fields of papers citing papers by Bo Zhai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Zhai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Zhai. The network helps show where Bo Zhai may publish in the future.

Co-authorship network of co-authors of Bo Zhai

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Zhai. A scholar is included among the top collaborators of Bo Zhai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Zhai. Bo Zhai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Hongye, Zhigang Zheng, Yan Lin, et al.. (2025). IDO1 inhibition enhances CLDN18.2-CAR-T cell therapy in gastrointestinal cancers by overcoming kynurenine-mediated metabolic suppression in the tumor microenvironment. Journal of Translational Medicine. 23(1). 275–275. 5 indexed citations
2.
3.
Yan, Hui, et al.. (2024). Distribution of blood lead and cadmium levels in healthy children aged 0 to 18 years and analysis of related influencing factors in Henan, China: data findings from 2017 to 2022. ˜The œItalian Journal of Pediatrics/Italian journal of pediatrics. 50(1). 43–43. 2 indexed citations
4.
5.
Yan, Hui, et al.. (2023). The Impact of Non-pharmacological Interventions Measures Against COVID-19 on Respiratory Virus in Preschool Children in Henan, China. Journal of Epidemiology and Global Health. 14(1). 54–62. 7 indexed citations
6.
Yan, Hui, Qiang Zhou, Fang Yang, et al.. (2023). CCNB1IP1 prevents ubiquitination‐mediated destabilization of MYCN and potentiates tumourigenesis of MYCN‐amplificated neuroblastoma. Clinical and Translational Medicine. 13(7). e1328–e1328. 5 indexed citations
7.
Zhang, Hui‐Lu, Ping Chen, He‐Xin Yan, et al.. (2022). Targeting mTORC2/HDAC3 Inhibits Stemness of Liver Cancer Cells Against Glutamine Starvation. Advanced Science. 9(20). e2103887–e2103887. 28 indexed citations
8.
Chi, Jiachang, Min Ding, Zhi Wang, et al.. (2021). Pathologic Diagnosis and Genetic Analysis of Sequential Biopsy Following Coaxial Low-Power Microwave Thermal Coagulation For Pulmonary Ground-Glass Opacity Nodules. CardioVascular and Interventional Radiology. 44(8). 1204–1213. 8 indexed citations
9.
Shi, Donghua, Yao Shi, Ahmed O. Kaseb, et al.. (2020). Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials. Clinical Cancer Research. 26(15). 3979–3989. 254 indexed citations
10.
Li, Weijian, Xuejing Zhu, Zhenyu Wang, et al.. (2020). An extracorporeal bioartificial liver embedded with 3D-layered human liver progenitor-like cells relieves acute liver failure in pigs. Science Translational Medicine. 12(551). 31 indexed citations
11.
Li, Weidong, Xuesong Dong, Changjun He, et al.. (2019). LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells. Journal of Experimental & Clinical Cancer Research. 38(1). 183–183. 162 indexed citations
12.
Fu, Gongbo, Weijian Huang, Min Zeng, et al.. (2018). Expansion and differentiation of human hepatocyte-derived liver progenitor-like cells and their use for the study of hepatotropic pathogens. Cell Research. 29(1). 8–22. 117 indexed citations
13.
Takada, Mamoru, Weiguo Zhang, Aussie Suzuki, et al.. (2017). FBW7 Loss Promotes Chromosomal Instability and Tumorigenesis via Cyclin E1/CDK2–Mediated Phosphorylation of CENP-A. Cancer Research. 77(18). 4881–4893. 67 indexed citations
14.
Zeng, Min, Gongbo Fu, Yuan Zhang, et al.. (2017). Maintaining viability and characteristics of cholangiocarcinoma tissue by vitrification-based cryopreservation. Cryobiology. 78. 41–46. 5 indexed citations
15.
Chen, Zhongjian, Fang Li, Bo Zhai, et al.. (2016). Efficacy analysis on arterial catheter stents for pulmonary atresia with intact ventricular septum in newborns. Zhonghua shiyong erke linchuang zazhi. 31(23). 1795–1798.
16.
17.
Zhai, Bo, Fengli Hu, Xian Jiang, et al.. (2014). Inhibition of Akt Reverses the Acquired Resistance to Sorafenib by Switching Protective Autophagy to Autophagic Cell Death in Hepatocellular Carcinoma. Molecular Cancer Therapeutics. 13(6). 1589–1598. 245 indexed citations
18.
Dong, Xiaofeng, Rui Li, Peng Xiu, et al.. (2014). Meloxicam Executes Its Antitumor Effects against Hepatocellular Carcinoma in COX-2- Dependent and -Independent Pathways. PLoS ONE. 9(3). e92864–e92864. 39 indexed citations
19.
Dong, Xuesong, Lele Lin, Xian Jiang, et al.. (2013). Up‐regulation of survivin by AKT and hypoxia‐inducible factor 1α contributes to cisplatin resistance in gastric cancer. FEBS Journal. 281(1). 115–128. 77 indexed citations
20.
Yan, He‐Xin, Wen Yang, Rui Zhang, et al.. (2006). Protein-tyrosine Phosphatase PCP-2 Inhibits β-Catenin Signaling and Increases E-cadherin-dependent Cell Adhesion. Journal of Biological Chemistry. 281(22). 15423–15433. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rishu Takimoto Breakdown of academic impact, for papers by Eiso Hiyama Breakdown of academic impact, for papers by Xueli Bai Breakdown of academic impact, for papers by Ning Ren Breakdown of academic impact, for papers by Runqiu Jiang Breakdown of academic impact, for papers by Qiongzhu Dong Breakdown of academic impact, for papers by Zhiyong Guo Breakdown of academic impact, for papers by Jesús M. Bañales Breakdown of academic impact, for papers by Jun Akiba
Rankless by CCL
2026